Quest to Help Diabetic Son Endures With a Different Kind of Giving
By Paul Sullivan, New York Times
Like any parent of a sick child, Sean Doherty wanted to help his son, Finn, who has Type 1 diabetes. Unlike many parents, he had the professional and personal resources to actually make a difference.
Four years ago, Mr. Doherty, then the general counsel of the private equity firm Bain Capital, teamed up with other parents of children with Type 1 diabetes to create the T1D Fund, a private equity-like investment vehicle organized as a nonprofit. The idea was to give a financial incentive to drug companies to develop a cure for Type 1 diabetes, an autoimmune disease that’s different from the more common Type 2 diabetes.